TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Investing
The Best Stock to Short Sell in 2018
Investing
5 Non-Cannabis Stocks That Doubled in 2017

Dividend Stocks
Rebalancing Your Portfolio for the New Year? Consider These 2 Principles
Investing
Which Marijuana Stock Is Today’s Best Bet?
Investing
Year in Review: My Top Marijuana Growth Stock for 2017
Investing
Cannabis Investors: Why Now May Be a Good Time to Play With the House’s Money

Investing
Will Canada’s Cannabis Market Really Be 40% Larger Than California’s in 2018?

Investing
Canopy Growth Corp.: A Good Time to Buy?

Investing
My Top Stock Pick for 2018: Marijuana Investing

Investing
Canadian Marijuana Stocks to Buy as the Germany Battle Intensifies

Investing
Canopy Growth Corp. Stock: Is There Any Upside Left for 2018?
